Kontakt 2006, 8(2):355-357 | DOI: 10.32725/kont.2006.056

Gene of dependence on nicotineBiomedicine

Jiří Patočka1,*, Anna Strunecká2
1 Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta, katedra radiologie a toxikologie
2 Univerzita Karlova v Praze, Přírodovědecká fakulta, katedra fyziologie živočichů a vývojové biologie

By smoking tobacco we mean inhalation of the smoke from burning dried tobacco leaves. This practice was common in many original inhabitants of America and it was brought into the rest of the world by sailors, who participated in first voyages of Europeans to the American continent. The most common form of smoking tobacco is smoking cigarettes. The tobacco smoke contains nicotine, which is a substance temporarily stimulating the alertness and memory, but it simultaneously induces a strong physical and mental dependence. Medical research demonstrated that smoking considerably participates in many health problems, particularly lung cancer, emphysema and cardiovascular diseases. Thus, a number of countries try to restrict sales of tobacco products and by restricting their advertisements and by prohibiting smoking at public places, they try to diminish effects of the smoke on non-smokers. Nicotine is a primary addictive substance in smoking tobacco. In this short review, we consider the dependence on nicotine and genetics of smokers with respect to cytochrome P450 (CYP2A6). In humans, nicotine is inactivated by its biotransformation to cotinine and CYP2A6 makes about 90% of this conversion. However, not all the people believe that genetic variations in CYP2A6 may play their important role in smoking. We summarize certain more recent findings about effects of the CYP2A6 genetic polymorphism, pharmacokinetics of nicotine, behaviour of smokers and concepts concerning possible ways of affecting different effects in the course of particular smoking stages by genes. Application of these findings to new and original methods of stopping smoking is discussed. Persons with slow metabolic conversion of nicotine and those with prevalent symptoms of depression are at enhanced risk of the dependence on nicotine.

Keywords: smoking; nicotine; biotransformation; CYP2A6; genetics

Published: December 15, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Patočka J, Strunecká A. Gene of dependence on nicotine. Kontakt. 2006;8(2):355-357. doi: 10.32725/kont.2006.056.
Download citation

References

  1. BENOWITZ, N. L. et al.: Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther. 2006. Vol. 79, no 5, s. 480-488. Go to original source... Go to PubMed...
  2. BOHN, L. M., LEFKOWITZ, R. J., CARON, M. G.: Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci. 2002. Vol. 22, no 23, s. 10494-10500. Go to original source... Go to PubMed...
  3. CICERO, T. J. et al.: Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol. Drug Saf. 2005. Vol. 14, no 12, s. 851-859. Go to original source... Go to PubMed...
  4. DAFNY, N., YANG, P. B.: The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: A review of its locomotor effects. Brain Res. Bull. 2006. Vol. 68, no 6, s. 393-405. Go to original source... Go to PubMed...
  5. FUKAMI, T. et al.: A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo. Clin. Pharmacol. Ther. 2004. Vol. 76, no 6, s. 519-527. Go to original source... Go to PubMed...
  6. CHAMPTIAUX, N., CHANGEUX, J. P.: Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 2002. Vol., no 4, s. 319-330. Go to original source... Go to PubMed...
  7. KIM, D. S., PALMITER, R. D.: Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice. Proc. Natl. Acad. Sci. U S A. 2003. Vol. 10, no 3, s. 1346-1351. Go to original source... Go to PubMed...
  8. MALAIYANDI, V. et al.: Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol. Psychiatry. 2006. Vol. 11, no 4, s. 400-409. Go to original source... Go to PubMed...
  9. McCLEARN, G. E. et al.: Developmental loss of effect of a Chromosome 15 QTL on alcohol acceptance. Mamm. Genome. 1998. Vol. 9, no 12, s. 991-994. Go to original source... Go to PubMed...
  10. NAKAJIMA, M. et al.: Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. J. Clin. Pharmacol. 2006. Vol. 46, no 3, s. 337-344. Go to original source... Go to PubMed...
  11. NAKAJIMA, M.. et al.: Novel human CYP2A6 alleles confound gene deletion analysis. FEBS Lett. 2004. Vol. 569, no 1-3, s. 75-81. Go to original source... Go to PubMed...
  12. OZAKI, S. et al.: Smoking cessation program and CYP2A6 polymorphism. Front. Biosci. 2006. Vol. 11, s. 2590-2597. Go to original source... Go to PubMed...
  13. ROSSINI, A. et al.: CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro. J. Med. Biol. Res. 2006. Vol. 39, no 2, s. 195-201. Go to original source...
  14. RUSTAY, N. R., WAHLSTEN, D., CRABBE, J.C.: Assessment of genetic susceptibility to ethanol intoxication in mice. Proc. Natl. Acad. Sci. U S A. 2003. Vol. 100, no 5, s. 2917-2922. Go to original source... Go to PubMed...
  15. SYLVI-NELAGO, S., PATOČKA, J.: Morfínový typ drogové závislosti. In: Kontakt, České Budějovice: JU ZSF 2003. Vol. 5, no 4, s. 255-257.
  16. YAMANAKA, H. et al.: Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. Eur. J. Pharm. Sci. 2004. Vol. 22, no 5, s. 419-425. Go to original source... Go to PubMed...
  17. YOSHIDA, R. et al.: Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br. J. Clin. Pharmacol. 2002. Vol. 54, no 5, s. 511-517. Go to original source... Go to PubMed...